Cumberland Pharmaceuticals (CPIX) EBT Margin (2010 - 2026)
Cumberland Pharmaceuticals (CPIX) posted EBT Margin of 34.36% for Q1 2026, down 237.55% sequentially from 10.18% in Q4 2025, and down 4506.0% YoY from 0.78% in Q1 2025.
Cumberland Pharmaceuticals (CPIX) EBT Margin (2010 - 2026) Analysis & Trends
Cumberland Pharmaceuticals has reported EBT Margin for 17 years, with the latest figure at 34.36% in Q1 2026.
- Quarterly EBT Margin fell 4506.0% year-over-year to 34.36% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 17.17% (down 909.0% YoY) and the FY2025 annual result came in at 6.31%, up 1076.0% from the prior year.
- EBT Margin fell to 34.36% in Q1 2026 per CPIX's latest filing, from 10.18% in the prior quarter.
- Over five years, EBT Margin peaked at 10.7% in Q1 2025 and troughed at 67.11% in Q4 2023.
- A 5-year average of 15.08% and a median of 12.49% in 2022 frame the typical range for EBT Margin.
- The sharpest annual moves came in 2024 and 2026: EBT Margin soared 4834 bps in 2024, then sank 4506 bps in 2026.
- Over 5 years, EBT Margin stood at 26.43% in 2022, then sank by 154 bps to 67.11% in 2023, then jumped by 72 bps to 18.77% in 2024, then soared by 46 bps to 10.18% in 2025, then sank by 238 bps to 34.36% in 2026.
- According to Business Quant data, EBT Margin over the past three periods registered 34.36%, 10.18%, and 23.44% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | -10.99% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 35.09% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 13.34% |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 47.58% |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | -1.70% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 16.91% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 4.09% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Cumberland Pharmaceuticals | 117.68 Mn | 113.82 Mn | - | -1,862.51% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1,862.51% |
| Mar 31, 2026 | -34.36% |
| Dec 31, 2025 | -10.18% |
| Sep 30, 2025 | -23.44% |
| Jun 30, 2025 | -6.73% |
| Mar 31, 2025 | 10.70% |
| Dec 31, 2024 | -18.77% |
| Sep 30, 2024 | -16.79% |
| Jun 30, 2024 | -11.08% |
| Mar 31, 2024 | -22.25% |
| Dec 31, 2023 | -67.11% |
| Sep 30, 2023 | -10.47% |
| Jun 30, 2023 | 7.98% |
| Mar 31, 2023 | 1.94% |
| Dec 31, 2022 | -26.43% |
| Sep 30, 2022 | -3.65% |
| Jun 30, 2022 | -13.18% |
| Mar 31, 2022 | -12.49% |
| Dec 31, 2021 | -52.59% |
| Sep 30, 2021 | -19.52% |